Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
University of Florida
Eli Lilly and Company
Milton S. Hershey Medical Center
Milton S. Hershey Medical Center
Children's Oncology Group